Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225130 · ClinicalTrials.gov registry record · NA
Decreasing Suicide Risk Among Service Members With Posttraumatic Stress
A NA study, sponsored by Boston VA Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT04225130 is a NA study that has completed, run by Boston VA Research Institute. The registered enrollment target is 95 participants.
The verdict
NCT04225130, a NA study, has completed, sponsored by Boston VA Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
In this study, the investigators will conduct a randomized controlled trial (RCT) to evaluate the efficacy of the WET-S + treatment as usual (TAU) compared with TAU among high-risk, suicidal service members with PTSD or posttraumatic stress (PTS) admitted to the Carl R. Darnall Army Medical Center (CRDAMC) acute inpatient psychiatry unit at Fort Hood, Texas. Suicide risk and PTS symptom severity are the primary outcomes. Secondary outcomes include subsequent hospitalizations for suicidal thoughts and behaviors and suicide attempts. Investigators will conduct a needs assessment with stakeholders during the RCT to develop a tool kit for WET implementation in other DoD inpatient psychiatry units.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Written Exposure Therapy -for Suicide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04225130
The ClinicalTrials.gov registry entry for NCT04225130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston VA Research Institute, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT04225130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04225130 about?
NCT04225130 is a clinical study titled "Decreasing Suicide Risk Among Service Members With Posttraumatic Stress". In this study, the investigators will conduct a randomized controlled trial (RCT) to evaluate the efficacy of the WET-S + treatment as usual (TAU) compared with TAU among high-risk, suicidal service members with PTSD or posttraumatic stress (PTS) admitted to the Carl R. Darnall Army Medical Center (...
What is the current status of trial NCT04225130?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2020-01-09. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04225130?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Written Exposure Therapy -for Suicide (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225130?
This trial is sponsored by Boston VA Research Institute, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.